rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1986-6-10
|
pubmed:abstractText |
A double-blind, placebo-controlled crossover study was conducted to examine the effects of long-acting propranolol in the treatment of violent behavior associated with organic brain disease in 10 patients whose symptoms had proved refractory to various conventional medications. Long-acting propranolol treatment was associated with reductions of assaultive behavior without apparent sedative effects. Cautions are noted regarding potential undesirable side effects which may necessitate careful patient monitoring during treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-3018
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
174
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
290-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3517228-Adult,
pubmed-meshheading:3517228-Aged,
pubmed-meshheading:3517228-Aggression,
pubmed-meshheading:3517228-Clinical Trials as Topic,
pubmed-meshheading:3517228-Delayed-Action Preparations,
pubmed-meshheading:3517228-Delirium, Dementia, Amnestic, Cognitive Disorders,
pubmed-meshheading:3517228-Dose-Response Relationship, Drug,
pubmed-meshheading:3517228-Double-Blind Method,
pubmed-meshheading:3517228-Hospitalization,
pubmed-meshheading:3517228-Humans,
pubmed-meshheading:3517228-Impulsive Behavior,
pubmed-meshheading:3517228-Male,
pubmed-meshheading:3517228-Middle Aged,
pubmed-meshheading:3517228-Placebos,
pubmed-meshheading:3517228-Propranolol,
pubmed-meshheading:3517228-Psychotropic Drugs,
pubmed-meshheading:3517228-Violence
|
pubmed:year |
1986
|
pubmed:articleTitle |
Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|